The genetic basis of epidermolysis bullosa, a group of genetic disorders characterized by the mechanically induced formation of skin blisters, is largely known, but a number of cases still remain genetically unsolved. Here, we used whole-exome and targeted sequencing to identify monoallelic mutations, c.1A>G and c.2T>C, in the translation initiation codon of the gene encoding kelch-like protein 24 (KLHL24) in 14 individuals with a distinct skin-fragility phenotype and skin cleavage within basal keratinocytes. Remarkably, mutation c.1A>G occurred de novo and was recurrent in families originating from different countries. The striking similarities of the clinical features of the affected individuals point to a unique and very specific pathomechanism. We showed that mutations in the translation initiation codon of KLHL24 lead to the usage of a downstream translation initiation site with the same reading frame and formation of a truncated polypeptide. The pathobiology was examined in keratinocytes and fibroblasts of the affected individuals and via expression of mutant KLHL24, and we found mutant KLHL24 to be associated with abnormalities of intermediate filaments in keratinocytes and fibroblasts. In particular, KLHL24 mutations were associated with irregular and fragmented keratin 14. Recombinant overexpression of normal KLHL24 promoted keratin 14 degradation, whereas mutant KLHL24 showed less activity than the normal molecule. These findings identify KLHL24 mutations as a cause of skin fragility and identify a role for KLHL24 in maintaining the balance between intermediate filament stability and degradation required for skin integrity.
Inherited epidermolysis bullosa (EB) is a group of genetic disorders characterized by skin fragility and blister formation after trivial mechanical trauma. 1 In spite of the advanced knowledge of the molecular basis of EB and extensive genetic testing, a number of cases remain genetically unsolved. [2] [3] [4] [5] The most common EB type, EB simplex (MIM: 131800, 131960, 131760, 131900, 609352, and 601001), is mainly caused by monoallelic mutations in KRT5 (MIM: 148040) and KRT14 (MIM: 148066), which encode keratin 5 and keratin 14, respectively, the major intermediate filaments (IFs) expressed in basal keratinocytes of the epidermis. Most KRT5 and KRT14 mutations have a dominant-negative effect and weaken the mechanical resistance of keratin IFs in basal epidermal keratinocytes, resulting in skin cleavage within this epidermal layer. 6 Furthermore, mutations in three other genes, PLEC (MIM: 601282), DST (MIM: 113810), and EXPH5 (MIM: 612878), account for rare subtypes of basal EB simplex (MIM: 226670, 612138, 131950, 616487, 615425, and 615028).
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Here, we combined deep phenotyping and wholeexome sequencing (WES) and identified monoallelic mutations in the translation initiation codon of KLHL24 (MIM: 611295), encoding kelch-like protein 24 (KLHL24), in 14 individuals from ten families affected by genetically unsolved EB simplex. The families were unrelated and originated from Germany, Switzerland, Finland, Qatar, and Italy. The study included a total of 53 family members, 14 of whom had skin fragility, and 39 of whom were not affected. The clinical phenotype was remarkably consistent across all affected individuals and allowed for the prediction of a common genotype. In three families (A, B, and J), the inheritance was autosomal dominant, whereas the other seven families (C-I) showed simplex cases of disease (Table S1 and Figures 1 and S1 ). The clinical features changed with age, but all children and adults had similar cutaneous manifestations (compare Figures 1 and S2 ). Extensive skin defects were present on the extremities at birth (aplasia cutis congenita), leaving behind hypopigmentation and atrophy with a whirled pattern. Generalized blistering persisted during childhood and healed with cutaneous and follicular atrophy, linear and stellate scars, and hypopigmentation (Figures 1 and S2 ). Toenails were fragile and became progressively thicker. The cutaneous fragility decreased in adulthood. The adults had dyspigmentation and atrophy of the skin, scars, follicular atrophoderma, sparse body hair, progressive diffuse alopecia of the scalp, diffuse palmoplantar keratoderma, and nail changes (shown in Figures 1 and S2 and summarized in Table S1 ). The unique characteristics of this phenotype were hair loss and follicular and cutaneous atrophy and scarring, features that are not present in persons with classic forms of EB simplex.
The study was performed according to a protocol approved by the ethics committee of the University of Freiburg, and written consent was obtained prior to sample collection. DNA from blood and cultured cells was obtained with the QIAmp DNA Mini Kit (QIAGEN). Skin biopsies of the index subjects and healthy individuals who underwent surgery were obtained after informed written consent was provided and were used for morphological analyses and cell isolation.
The classification as EB simplex was based on the level of skin cleavage, which was determined by H&E or transmis- Figures 1D-1F ). The ultrastructural level of cleavage was located above the hemidesmosomes, close to the basement membrane. The morphology of the keratin IFs, the hemidesmosomes, and the basement membrane appeared normal ( Figure 1E ). Hemidesmosomal proteins, plectin, and integrin b4 stained at the floor of the blisters ( Figure 1F ), and the staining intensity of the DEJ markers was comparable to that of control skin.
In a candidate approach, genes involved in EB were sequenced in all index subjects, but no pathogenic changes were found. WES was then employed in families A (affected mother AII.2 and daughter AIII.1; and unaffected parents AI.1 and AI.2), B (affected siblings BIII.1 and BIII.2), and E (affected EII.1 and unaffected parents). WES was performed by BGI with the AgilentSureSelect All Exon Kit on the Illumina HiSeq 4000 platform. Reads were aligned to the human reference sequence (UCSC Genome Browser hg19) with the Burrows-Wheeler Aligner and trimmed to targeted intervals with Picard. Table S2 ). Furthermore, c.1A>G (p.Met1?) was disclosed in a heterozygous state in all affected individuals of families C, D, and F-J but in none of the unaffected relatives. Importantly, by testing a total of 53 individuals, including the healthy parents of the index subjects, we provide clear evidence that mutations perfectly segregated with the phenotype in each family and occurred de novo ( Figures 1C, 2A and 2B, and S1). Variants c.1A>G and c.2T>C were absent in cohorts of healthy control subjects in dbSNP, 1000 Genomes, the Exome Variant Server, and the ExAC Browser. They were predicted to change the Kozak consensus sequence and shift the start codon of KLHL24. For both c.1A>G and c.2T>C, the prediction of Mutation Taster 13 was ''disease causing'' with a probability of 0.99. As a consequence, a downstream translation initiation site with the same reading frame resulting in a 28-aa-shortened sequence was predicted in silico ( Figure 2C ). This hypothesis was experimentally verified by recombinant expression of normal and mutant KLHL24 cDNA. For validation of the results and better separation by SDS-PAGE, we designed both full-length and short forms of recombinant KLHL24. In brief, full-length KLHL24 cDNA (from cDNA position 1 to the penultimate codon) and the short form (from cDNA position 1 to position 409, corresponding to the first 136 codons) were amplified by PCR with REDTaq DNA Polymerase (Sigma-Aldrich) (the specific primers are listed in Table S2 ). The PCR products were cloned into the pcDNA3.1∕CT-GFP-TOPO vector, and competent DH5a E. coli (Thermo Fisher Scientific) were transformed according to the manufacturer's instructions. Plasmids encoding mutant KLHL24 were obtained by site-directed mutagenesis with the QuikChange II Kit (Agilent Technologies), specific primers (Table S2) , and the pcDNA3. Figure 2D ). Very little is known about KLHL24, which encodes KLHL24, and no related human disease has been reported so far. KLHL24 has been shown to form homodimers and to regulate the function of kainate receptors in neurons, 14, 15 but it has not yet been linked to epidermal integrity. KLHL24 belongs to the BTB/kelch family, which comprises a large group of highly conserved proteins involved in diverse cellular functions, including cytoskeleton interactions, nuclear transcription, and ubiquitination. [16] [17] [18] In the N terminus, BTB (bric a brac 1, tramtrack, and broad) domains facilitate dimerization and protein binding. In particular, BTB domains bind to cullins, E3 ligase adapters, to target substrates for ubiquitin-dependent degradation by the 26S proteasome. 19, 20 N-terminal truncation due to the mutations in the translation initiation codon of KLHL24 can affect functions of this region, such as dimerization and protein interactions, thus having a dominant-negative effect. Kelch domains form a tertiary structure of b-propellers, which have a role in binding to specific proteins targeted for degradation. 18 One of the best-known KLHL proteins, KLHL19 (also known as Keap1, encoded by KEAP1 [MIM: 606016]), is an oxidative-stress sensor that functions as an adaptor for cullin-3-based E3 ligase to regulate proteasomal degradation of the antioxidant transcription factor NRF2. 21 Mutations in several BTB/kelch family members are associated with human monogenic diseases; for example, monoallelic mutations in KLHL3 (MIM: 605775) cause familial hyperkalemic 27 Gigaxonin, the substrate adaptor of an E3 ubiquitin ligase, emerged as the first IF regulator and is responsible for controlling the turnover of neurofilaments in addition to other IFs. 28, 29 The normal physiological role of gigaxonin is in the maintenance of cytoskeletal structures in normal tissues, including the processing of intermediate neural filaments in neural cells and vimentin in fibroblasts and endothelial cells. 30 Thus, we studied the expression of KLHL24 in skin and skin cells. Normal human keratinocytes were cultured in keratinocyte growth medium (Invitrogen), and dermal fibroblasts were grown in DMEM supplemented with 10% FCS, 1% L-glutamine, and 1% pyruvate (Invitrogen). Human normal melanocytes were purchased from PromoCell and grown in melanocyte growth medium (PromoCell). RNA was isolated with the RNAeasy Mini Kit (QIAGEN), transcribed into cDNA with the First Strand cDNA Synthesis Kit (Fermentas), and subjected to RT-PCR (primers are listed in Table S2 ). We found expression of KLHL24 in all main skin cell types: keratinocytes, dermal fibroblasts, and melanocytes ( Figure S3A ). Next, immunofluorescence staining was performed on skin cryosections or on keratinocytes, which were seeded on coverslips, allowed to adhere and grow for 2 days, fixed with acetone and methanol, and processed as previously described 31 (antibodies are listed in Table S3 ). In skin and keratinocytes, KLHL24 was detected with a commercially available antibody (Abcam) intracellularly and at the cell periphery, where it partially colocalized with desmoplakin, a marker of desmosomes, and with E-cadherin, a component of adherens junctions (Figures S3B and S3C ).
To assess the molecular consequences of KLHL24 mutations, we generated cell lines from primary cells of individuals DIII.1 and EII.1 and control individuals by transduction with the HPV E6E7 genes (the construct was a kind gift from Dr. Fernando Larcher, and the helper plasmids were a gift from Dr. Stefanie Löffek) as described before. 32 Mutations were confirmed in all cell lines (data not shown). As shown by RT-PCR, the mutations in the start codon of KLHL24 did not result in reduced transcription or mRNA decay in keratinocytes or fibroblasts derived from the affected individuals ( Figures 2E and S3D) . Immunostaining of KLHL24 demonstrated a different staining pattern between mutant keratinocytes (reduction of the signal in the cytoplasm and at the cell periphery) and normal human keratinocytes ( Figure 2F ). To validate the specificity of the antibody, we used normal human keratinocytes in which the expression of KLHL24 had been knocked down by 75% ( Figure S3E ) with siRNA duplexes specific to KLHL24 (Table S4 ) (Eurogentec) and Lipofectamine 2000 (Invitrogen). Like other kelch-like family members, KLHL24 might be involved in protein ubiquitination, particularly the turnover of IF proteins, in a manner similar to that of gigaxonin. IF turnover is a highly dynamic process required for maintaining tissue integrity and is implicated in degenerative and regenerative processes. 29 Keratin IFs are crucial for maintaining cell and tissue integrity in that they act as structural scaffolds and are dynamic enough to sustain several additional processes. Keratins serve multiple homeostatic and stress-enhanced mechanical and non-mechanical functions in epithelia, including the maintenance of cellular integrity, regulation of cell growth and migration, and protection from apoptosis. 33 Keratin IFs display highly dynamic properties in response to injury, sometimes in the form of degradation of the keratin IF network. 34 Phosphorylation targets keratin proteins for degradation in these circumstances, and the turnover is regulated by the ubiquitin proteasome pathway. [34] [35] [36] [37] To address the hypothesis that KLHL24 mutations affect the degradation of keratins, we assessed keratins 5 and 14 in skin and cultured keratinocytes. Both keratins stained positive in skin sections of the individuals with KLHL24 mutations, although cytolysis of basal keratinocytes was very often observed ( Figure 2G ). In cultured keratinocytes of the individuals with KLHL24 mutations, keratin 14 staining (clones LL002 and EP1612Y) appeared disorganized, irregular, and fragmented, whereas keratin 5 (clone D5/16 B4 and polyclonal antibody), tubulin, and actin were not significantly changed ( Figures 2H and S4A) . The amounts of keratins 5 and 14 were 1.5-to 2-fold higher in whole-cell lysates 33 of KLHL24 mutant keratinocytes than in control cells ( Figure 2I ). Similar results were obtained after fractionation of soluble and insoluble protein 33 (data not shown). Because keratin 15, a type I keratin present in minor amounts in basal keratinocytes, has been shown to form heterodimers with keratin 5 38 and have a compensatory effect on the skin of humans with keratin 14 variants, 39 we assessed the expression and abundance of keratin 15 (clone EPR1614Y) in the skin and keratinocytes of affected individuals and found a strong upregulation in comparison with control samples ( Figures 2G-2I and S4B). All together, these findings suggest that mutations leading to N-terminal truncation of KLHL24 affect basal epidermal keratins, in particular keratin 14. Next, we used heat stress to challenge the keratin IFs and induce their disruption in keratinocytes. 40 In brief, cells were grown to subconfluence on coverslips, culture medium was replaced with prewarmed 43 C medium, and dishes were placed in a 43 C incubator for 15 min.
Thereafter, the dishes were placed back at 37 C, and coverslips were fixed with ice-cold methanol and acetone, air-dried, blocked, and incubated with the primary antibodies. In the keratinocytes of the individuals with KLHL24 mutations, the abnormalities of keratin 14 were (legend continued on next page) even more pronounced with perinuclear distribution and fragmentation, suggesting increased depolymerization 41 after stress induction, whereas control cells changed very little ( Figures 3A and 3B ). The overall abundance of ubiquitinated proteins increased in control cells after heat stress but did not change significantly in the cells of the individuals with KLHL24 mutations (Figures 3C and S4C ). Confocal microscopy (LSM510, Carl Zeiss) showed that ubiquitin colocalized with keratin 14 in cells from a control individual and a person with EB simplex due to a mutation affecting keratin 14 (c.373C>T [p.Arg125Cys]). In contrast, in basal cell-culture conditions, particularly after heat stress, ubiquitin was not present in the cytoplasm and did not colocalize with keratin 14 in the cells of the individuals with KLHL24 mutations (Figures 3D  and S4C ). Because stress-inducible kinase p38 was hyperactivated in keratinocytes from persons with EB simplex caused by mutations affecting keratin 5 or keratin 14 in basal culture conditions and further increased after osmotic or heat stress, 42, 43 we tested whether this was also the case in KLHL24 mutant keratinocytes. We observed augmented phosphorylation of the stress-activated kinase p38 and, in line with this, an approximately 2-fold increase in the apoptosis (In Situ Cell Death Detection Kit, TMR red, Roche) of KLHL24 mutant keratinocytes in basal cell-culture conditions and after heat stress ( Figure S5 ). These results suggest that ubiquitination and subsequent proteasomal degradation of keratin 14 might be disturbed in the presence of the KLHL24 mutations and thus result in cellular stress and apoptosis.
To directly address the effect of normal and mutant KLHL24 on keratin 14 degradation, we assessed keratin 14 by immunofluorescence staining after recombinant overexpression of the GFP-tagged normal and mutant KLHL24 cDNAs in HaCaT keratinocytes. 44 Of the cells overexpressing normal KLHL24, 72% were negative for keratin 14, supporting the hypothesis that, like gigaxonin, 28 KLHL24 promotes IF degradation. In contrast, 41%
of the cells expressing mutant KLHL24 preserved the keratin 14 staining ( Figures 3E and 3F) , suggesting that the mutants have a lower ability to promote keratin 14 degradation than the normal molecule. Finally, a broader role of KLHL24 in the regulation of IFs is supported by the observation of fragmented vimentin IF in the fibroblasts of the individuals with KLHL24 mutations, whereas the actin cytoskeleton always appeared normal ( Figure S6 ).
We provide strong genetic data that imply mutations in the translation initiation codon of KLHL24 as the cause of a distinct skin-fragility phenotype, which can be classified as EB simplex given the ultrastructural level of skin cleavage. Remarkably, mutation c.1A>G occurred de novo and was recurrent in families originating from different countries. The striking similarities of the clinical features point to a unique and very specific pathomechanism, which remains to be clarified in detail. In this regard, it is expected that nucleotide changes in the third position of the translation initiation codon (c.3G>A, c.3G>T, or c.3G>C) might also result in the same phenotype. We have shown that KLHL24 is expressed in keratinocytes, dermal fibroblasts, and melanocytes (the main cells of the skin) and that it affects the ubiquitination and probably the proteasomal degradation of IFs, particularly keratin 14 in keratinocytes and vimentin in fibroblasts. Nevertheless, other targets and functions cannot be excluded.
The identified mutations lead to the formation of an N-terminally-truncated polypeptide that interferes with the physiological function of KLHL24, as shown by recombinant expression in HaCaT cells. The mutations do not alter KLHL24 mRNA levels but rather change the protein amount and activity. Most data on the plasticity of the keratin network have been generated with cultured cells that overexpress fluorescence-tagged keratins, whereas the processes taking place in functional epithelial tissues remain largely unknown. 45 The abnormalities observed in authentic mutant keratinocytes include disorganization and fragmentation of keratin 14, which was more abundant than in control cells, suggesting an abnormal degradation. In the skin, where IF turnover is much lower than in cell culture, the anomalies demonstrated by immunostaining and TEM were mainly associated with cytolysis of the basal keratinocytes. The in vivo turnover of keratins is critical during development, when active cell division takes place in response to environmental stressors, and probably during differentiation of basal keratinocytes to the suprabasal layer. The observed anomalies of keratin 14 might correlate with the pronounced skin fragility at birth and the spontaneous alleviation in adulthood, noted in the KLHL24-mutationaffected individuals examined in this study. Upregulation of keratin 15 might also contribute to the keratin network in mutant keratinocytes, but keratin 5 and keratin 15 filaments cannot provide sufficient mechanical strength to withstand physical trauma. 38 We noted both certain similarities and differences between the biological phenotypes of keratinocytes with mutations affecting KLHL24 and keratin 14. Of particular interest is the increased p38 phosphorylation observed in KLHL24 mutant keratinocytes. It was reported that phosphorylated p38 colocalized with keratin during mitosis in various stress situations and in cells producing mutant keratins. In all of these situations, keratin 8 became phosphorylated on Ser73, a wellknown p38 target site. The p38-dependent signaling is a major intermediate-filament-regulating pathway with rapid and reversible effects on keratin phosphorylation and organization in diverse physiological, stress, and pathological situations. 6, 46 Nevertheless, the distinct phenotype associated with KLHL24 mutations does not overlap the clinical pictures observed in individuals with EB simplex (MIM: 131760, 131900, 601001, and 131800) due to dominant missense or recessive null mutations affecting keratin 14 1 or in individuals with Naegeli syndrome (MIM: 161000) due to keratin 14 haploinsufficiency. 47 The particular features of this phenotype (skin atrophy and scarring) could be explained by increased apoptosis of the keratinocytes, by anomalies of the fibroblasts' IFs, and by additional functions of KLHL24.
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